Q1 2023 EPS Estimates for Prestige Consumer Healthcare Inc. (NYSE:PBH) Reduced by Analyst

Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) – Analysts at Jefferies Financial Group reduced their Q1 2023 earnings per share estimates for Prestige Consumer Healthcare in a report released on Tuesday, May 10th. Jefferies Financial Group analyst S. Wissink now anticipates that the company will post earnings of $1.05 per share for the quarter, down from their prior estimate of $1.06. Jefferies Financial Group has a “Buy” rating and a $70.00 price objective on the stock. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q1 2024 earnings at $1.09 EPS, Q2 2024 earnings at $1.13 EPS, Q4 2024 earnings at $1.13 EPS and FY2024 earnings at $4.49 EPS.

Other analysts have also issued reports about the company. Oppenheimer raised Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 target price on the stock in a report on Monday. StockNews.com began coverage on shares of Prestige Consumer Healthcare in a report on Thursday, March 31st. They issued a “buy” rating on the stock. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $76.40.

Prestige Consumer Healthcare stock opened at $57.57 on Wednesday. The company has a market cap of $2.89 billion, a price-to-earnings ratio of 14.25, a PEG ratio of 1.60 and a beta of 0.58. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.25 and a current ratio of 2.04. The business’s fifty day moving average is $54.70. Prestige Consumer Healthcare has a one year low of $46.12 and a one year high of $63.83.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last announced its earnings results on Thursday, May 5th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Prestige Consumer Healthcare had a net margin of 18.90% and a return on equity of 14.08%. The firm had revenue of $266.94 million for the quarter, compared to analyst estimates of $258.25 million. During the same quarter in the prior year, the business posted $0.79 EPS. The business’s revenue was up 12.3% compared to the same quarter last year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PBH. BNP Paribas Arbitrage SA grew its position in Prestige Consumer Healthcare by 75.5% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 73,686 shares of the company’s stock worth $4,135,000 after acquiring an additional 31,706 shares during the last quarter. Allianz Asset Management GmbH raised its stake in shares of Prestige Consumer Healthcare by 43.5% during the third quarter. Allianz Asset Management GmbH now owns 32,942 shares of the company’s stock valued at $1,848,000 after acquiring an additional 9,983 shares during the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $8,111,000. CWM LLC bought a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth $1,930,000. Finally, Dean Investment Associates LLC increased its holdings in Prestige Consumer Healthcare by 1.1% in the third quarter. Dean Investment Associates LLC now owns 62,391 shares of the company’s stock valued at $3,501,000 after purchasing an additional 676 shares during the period.

About Prestige Consumer Healthcare (Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Further Reading

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.